EUVIMEDEUVIMED entdecken
Crossref

A pH-Responsive Controlled Release Platform Based on Honeycomb MnO 2 /Carboxymethyl Chitosan/Oxidized Hyaluronic Acid for Multimodal Therapy of Breast Cancer

Hongyu Lin, Huwei Bian, Junyao Li iD, Laidi Xu, Tao Jiang, Yong Kong iD

Molecular Pharmaceutics · 02.03.2026 · 23 (3) · 1942-1954

DOI: 10.1021/acs.molpharmaceut.5c01660 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, online erschienen am 29.01.2026. Verfasst von Hongyu Lin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Jiangsu Key Laboratory of Advanced Materials and Technology, School of Petrochemical Engineering, Changzhou University, Changzhou 213164, China. Hauptthemen laut MEDLINE: Chitosan, Hyaluronic Acid, Manganese Compounds, Oxides. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 59 Literaturangaben. Gefördert von: Natural Science Foundation of Jiangsu Province, Changzhou Municipal Science and Technology Bureau, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To enhance the therapeutic efficacy of breast cancer, multimodal therapy with the aid of a pH-responsive controlled release platform is proposed in this work. Indocyanine green (ICG) is loaded in honeycomb MnO2 (hMnO2) synthesized by a template method, which is coencapsulated with 5-fluorouracil (5-FU) in the hydrogels cross-linked between carboxymethyl chitosan (CMCS) and oxidized hyaluronic acid (OHA). The imine linkage (-HC═N-) between CMCS and OHA is hydrolyzed under weakly acidic conditions, leading to the release of 5-FU for chemotherapy and ICG/hMnO2. The hMnO2 can convert the optical energy of near-infrared (NIR) light into heat for photothermal therapy (PTT). Additionally, the hMnO2 can be reduced to Mn2+ at low pH and high glutathione (GSH) level, and the produced Mn2+ can further react with H2O2 to generate hydroxyl radicals (·OH) through a Fenton-like reaction for chemodynamic therapy (CDT). ICG can be simultaneously released during the reduction of hMnO2, which can catalyze the conversion of oxygen to singlet oxygen (1O2) upon exposure to NIR light for photodynamic therapy (PDT). Due to the synergistic effects of chemotherapy, PTT, CDT, and PDT, the developed ICG/hMnO2/5-FU/CMCS/OHA hydrogels can significantly inhibit the growth of the 4T1 mouse breast cancer cell line.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ChitosanHyaluronic AcidManganese CompoundsOxidesBreast NeoplasmsFemaleAnimalsHydrogen-Ion ConcentrationDelayed-Action PreparationsMiceFluorouracilCombined Modality TherapyCell Line, TumorIndocyanine GreenHydrogelsHumansOxidation-Reduction

Stichwörter der Autor:innen

carboxymethyl chitosanhoneycomb MnO2multimodal therapyoxidized hyaluronic acidpH-responsive controlled release platform

Substanzen

ChitosanHyaluronic AcidManganese CompoundsOxidesDelayed-Action Preparationscarboxymethyl-chitosanFluorouracilIndocyanine Greenmanganese dioxideHydrogels

Autor:innen und Institutionen

  • Jiangsu Key Laboratory of Advanced Materials and Technology, School of Petrochemical Engineering, Changzhou University, Changzhou 213164, China.
  • The Fifth Department of Orthopedics and Traumatology, Changzhou Municipal Hospital of Traditional Chinese Medicine, Changzhou 213003, China.

ORCID-Profile: Junyao Li, Yong Kong

Förderung

  • Natural Science Foundation of Jiangsu Province
  • Changzhou Municipal Science and Technology Bureau
  • National Natural Science Foundation of China
  • Administration of Traditional Chinese Medicine of Jiangsu Province

Zitieren

APA

Lin, H., Bian, H., Li, J., Xu, L., Jiang, T., & Kong, Y. (2026). A pH-Responsive Controlled Release Platform Based on Honeycomb MnO 2 /Carboxymethyl Chitosan/Oxidized Hyaluronic Acid for Multimodal Therapy of Breast Cancer. Molecular Pharmaceutics, 23(3), 1942-1954. https://doi.org/10.1021/acs.molpharmaceut.5c01660

Vancouver

Lin H, Bian H, Li J, Xu L, Jiang T, Kong Y. A pH-Responsive Controlled Release Platform Based on Honeycomb MnO 2 /Carboxymethyl Chitosan/Oxidized Hyaluronic Acid for Multimodal Therapy of Breast Cancer. Molecular Pharmaceutics. 2026;23(3):1942-1954. doi:10.1021/acs.molpharmaceut.5c01660

BibTeX
@article{Lin2026,
  author = {Lin, Hongyu and Bian, Huwei and Li, Junyao and Xu, Laidi and Jiang, Tao and Kong, Yong},
  title = {A pH-Responsive Controlled Release Platform Based on Honeycomb MnO 2 /Carboxymethyl Chitosan/Oxidized Hyaluronic Acid for Multimodal Therapy of Breast Cancer},
  journal = {Molecular Pharmaceutics},
  year = {2026},
  volume = {23},
  number = {3},
  pages = {1942--1954},
  doi = {10.1021/acs.molpharmaceut.5c01660}
}
Kostenlos starten →